Hyzaar
NDC 54868-3866
Product Information
Hyzaar is a NDA-approved product labeled by Physicians Total Care, Inc.. This drug is used to treat high blood pressure. It is supplied as a yellow product. This product entry covers the primary NDC 54868-3866 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
717
Code Structure Chart
Product Details
What is NDC 54868-3866?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LOSARTAN POTASSIUM (UNII: 3ST302B24A)
- LOSARTAN (UNII: JMS50MPO89) (Active Moiety)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- STARCH, CORN (UNII: O8232NY3SJ)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- ALUMINUM OXIDE (UNII: LMI26O6933)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 979464 - losartan potassium 100 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
- RxCUI: 979464 - hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet
- RxCUI: 979464 - HCTZ 12.5 MG / Losartan K+ 100 MG Oral Tablet
- RxCUI: 979464 - HCTZ 12.5 MG / Losartan Pot 100 MG Oral Tablet
- RxCUI: 979464 - HCTZ 12.5 MG / losartan potassium 100 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.